Serum adiponectin in a population sample of 64-year-old women in relation to glucose tolerance, family history of diabetes, autoimmunity, insulin sensitivity, C-peptide, and inflammation

Metabolism: Clinical and Experimental

Volumn 55, Issue 2, 2006, Pages 188-194

  Behre, Carl Johan ^a,b   Brohall, Gerhard ^a,b   Hulthe, Johannes ^b,c   Fagerberg, Björn ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; INSULIN; PROINSULIN;

ADULT; ANTHROPOMETRY; ARTICLE; AUTOIMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADIPONECTIN; AUTOANTIBODIES; BLOOD GLUCOSE; C-REACTIVE PROTEIN; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MIDDLE AGED; OBESITY;

EID: 30744455494     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.08.011     Document Type: Article

References (48)

1. Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, and J. Miyagawa Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83
2. T. Yokota, K. Oritani, I. Takahashi, J. Ishikawa, A. Matsuyama, and N. Ouchi Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages Blood 96 2000 1723 1732
3. N. Ouchi, S. Kihara, T. Funahashi, T. Nakamura, M. Nishida, and M. Kumada Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 107 2003 671 674
4. M. Matsuda, I. Shimomura, M. Sata, Y. Arita, M. Nishida, and N. Maeda Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis J Biol Chem 277 2002 37487 37491
5. N. Stefan, B. Vozarova, T. Funahashi, Y. Matsuzawa, C. Weyer, and R.S. Lindsay Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans Diabetes 51 2002 1884 1888
6. O. Tschritter, A. Fritsche, C. Thamer, M. Haap, F. Shirkavand, and S. Rahe Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism Diabetes 52 2003 239 243
7. K.M. Choi, J. Lee, K.W. Lee, J.A. Seo, J.H. Oh, and S.G. Kim Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans Clin Endocrinol (Oxf) 61 2004 75 80
8. B.B. Duncan, M.I. Schmidt, J.S. Pankow, H. Bang, D. Couper, and C.M. Ballantyne Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study Diabetes 53 2004 2473 2478
9. J. Spranger, A. Kroke, M. Mohlig, M.M. Bergmann, M. Ristow, and H. Boeing Adiponectin and protection against type 2 diabetes mellitus Lancet 361 2003 226 228
10. C. Snehalatha, B. Mukesh, M. Simon, V. Viswanathan, S.M. Haffner, and A. Ramachandran Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians Diabetes Care 26 2003 3226 3229
11. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, and Y. Okamoto Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599
12. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737
13. C. Zoccali, F. Mallamaci, and G. Tripepi Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease Nephrol Dial Transplant 19 Suppl 5 2004 V67 V72
14. M.P. Chen, J.C. Tsai, F.M. Chung, S.S. Yang, L.L. Hsing, and S.J. Shin Hypoadiponectinemia is associated with ischemic cerebrovascular disease Arterioscler Thromb Vasc Biol 2005
15. N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, and H. Nagaretani Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 Nat Med 8 2002 731 737
16. N. Kubota, Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, and J. Matsui Disruption of adiponectin causes insulin resistance and neointimal formation J Biol Chem 277 2002 25863 25866
17. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, and K. Hara The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 2001 941 946
18. J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson, and F.T. Yen Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc Natl Acad Sci U S A 98 2001 2005 2010
19. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat Med 7 2001 947 953
20. R.S. Lindsay, T. Funahashi, R.L. Hanson, Y. Matsuzawa, S. Tanaka, and P.A. Tataranni Adiponectin and development of type 2 diabetes in the Pima Indian population Lancet 360 2002 57 58
21. M. Daimon, T. Oizumi, T. Saitoh, W. Kameda, A. Hirata, and H. Yamaguchi Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata Study Diabetes Care 26 2003 2015 2020
22. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, and R.E. Pratley Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001 1930 1935
23. J.M. Bruun, A.S. Lihn, C. Verdich, S.B. Pedersen, S. Toubro, and A. Astrup Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans Am J Physiol Endocrinol Metab 285 2003 E527 E533
24. C.J. Behre, B. Fagerberg, L. Mattsson Hultén, and J. Hulthe The reciprocal association of adipocytokines with insulin resistance and CRP in clinically healthy men Metabolism 54 2005 439 444
25. F. Pellme, U. Smith, T. Funahashi, Y. Matsuzawa, H. Brekke, and O. Wiklund Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients Diabetes 52 2003 1182 1186
26. L. Niskanen, A. Turpeinen, I. Penttila, and M.I. Uusitupa Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis Diabetes Care 21 1998 1861 1869
27. WHO Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 1997 1183 1197
28. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation 97 1998 425 428
29. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
30. W.J. Sobey, S.F. Beer, C.A. Carrington, P.M. Clark, B.H. Frank, and I.P. Gray Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins Biochem J 260 1989 535 541
31. P.J. Bingley, E. Bonifacio, and P.W. Mueller Diabetes antibody standardization program: first assay proficiency evaluation Diabetes 52 2003 1128 1136
32. C. Kuhl, O.K. Faber, P. Hornnes, and S.L. Jensen C-peptide metabolism and the liver Diabetes 27 Suppl 1 1978 197 200
33. O.K. Faber, K. Christensen, H. Kehlet, S. Madsbad, and C. Binder Decreased insulin removal contributes to hyperinsulinemia in obesity J Clin Endocrinol Metab 53 1981 618 621
34. J.G. Yu, S. Javorschi, A.L. Hevener, Y.T. Kruszynska, R.A. Norman, and M. Sinha The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects Diabetes 51 2002 2968 2974
35. M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, and R. Paschke Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes Biochem Biophys Res Commun 290 2002 1084 1089
36. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746 26749
37. H. Waki, T. Yamauchi, J. Kamon, Y. Ito, S. Uchida, and S. Kita Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin J Biol Chem 278 2003 40352 40363
38. U.B. Pajvani, X. Du, T.P. Combs, A.H. Berg, M.W. Rajala, and T. Schulthess Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity J Biol Chem 278 2003 9073 9085
39. H. Kobayashi, N. Ouchi, S. Kihara, K. Walsh, M. Kumada, and Y. Abe Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin Circ Res 94 2004 e27 e31
40. U.B. Pajvani, M. Hawkins, T.P. Combs, M.W. Rajala, T. Doebber, and J.P. Berger Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity J Biol Chem 279 2004 12152 12162
41. M.B. Schulze, E.B. Rimm, I. Shai, N. Rifai, and F.B. Hu Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes Diabetes Care 27 2004 1680 1687
42. P.A. Kern, G.B. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression Diabetes 52 2003 1779 1785
43. J.L. Gonzalez-Sanchez, C.A. Zabena, M.T. Martinez-Larrad, C. Fernandez-Perez, M. Perez-Barba, and M. Laakso An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance Obes Res 13 2005 807 812
44. C. Lacquemant, P. Froguel, S. Lobbens, P. Izzo, C. Dina, and J. Ruiz The adiponectin gene SNP+45 is associated with coronary artery disease in type 2 (non-insulin-dependent) diabetes mellitus Diabet Med 21 2004 776 781
45. E. Filippi, F. Sentinelli, S. Romeo, M. Arca, A. Berni, and C. Tiberti The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years) J Mol Med 83 2005 711 719
46. K. Ohashi, N. Ouchi, S. Kihara, T. Funahashi, T. Nakamura, and S. Sumitsuji Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease J Am Coll Cardiol 43 2004 1195 1200
47. U. Salmenniemi, J. Zacharova, E. Ruotsalainen, I. Vauhkonen, J. Pihlajamaki, and S. Kainulainen Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure and cytokines in offspring of type 2 diabetic patients J Clin Endocrinol Metab 90 2005 4216 4223
48. M. Cnop, P.J. Havel, K.M. Utzschneider, D.B. Carr, M.K. Sinha, and E.J. Boyko Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 46 2003 459 469